Shenzhen Mindray signed a purchase and license agreement allowing it to use Masimo’s technology for noninvasive, continuous measurement of oxygen saturation, pulse rate, and perfusion index in its monitoring devices. The SET® Measure-through Motion and Low Perfusion™ pulse oximetry will be available in Mindray devices sold in some European countries, the Middle East, Asia-Pacific (excluding China), including Australia and India. The new pact expands an earlier agreement between the two companies. Masimo is headquartered in Switzerland.
Source: China Biotoday
